K. Ogata

发表

Timing of interferon therapy and sources of infection in patients with acute hepatitis C.

T. Ide, R. Kumashiro, M. Sata, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

The case of an elderly male patient with autoimmune hepatitis complicated by various immunological abnormalities

T. Ide, R. Kumashiro, M. Sata, 2010 .

First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study

T. Kawaguchi, H. Koga, T. Torimura, 2021, Cancer medicine.

Risk of malignancies in autoimmune hepatitis type 1 patients with a long‐term follow‐up in Japan

T. Kawaguchi, T. Ide, H. Koga, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis

T. Ide, R. Kumashiro, M. Sata, 2016, Journal of Gastroenterology.

A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon–ribavirin therapy

T. Ide, R. Kumashiro, M. Sata, 2008, Archives of Virology.

Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma

K. Ueshima, H. Koga, T. Ueno, 2021, Cancers.

Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.

T. Ide, R. Kumashiro, M. Sata, 2003, International Journal of Molecular Medicine.

A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan

M. Sata, T. Okanoue, Y. Niitsu, 2004, Journal of Gastroenterology.

Lamivudine treatment‐related morphological changes of esophageal varices in patients with liver cirrhosis

T. Ide, R. Kumashiro, M. Sata, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Predictive Factors Associated with the Progression to Hepatic Failure Caused by Lamivudine-Resistant HBV

T. Ide, R. Kumashiro, M. Sata, 2008, Digestive Diseases and Sciences.

Subclones of Drug-Resistant Hepatitis B Virus Mutants and the Outcome of Breakthrough Hepatitis in Patients Treated with Lamivudine

T. Ide, R. Kumashiro, M. Sata, 2003, Intervirology.

A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine

T. Ide, R. Kumashiro, M. Sata, 2003, American Journal of Gastroenterology.

Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment

T. Ide, R. Kumashiro, M. Sata, 2005, Journal of Gastroenterology.

Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine.

R. Kumashiro, M. Sata, S. Murashima, 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy

T. Ide, R. Kumashiro, M. Sata, 2004, Journal of medical virology.

Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels.

T. Ide, R. Kumashiro, M. Sata, 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

A Randomized Study of Extended Treatment With Peginterferon α-2b Plus Ribavirin Based on Time to HCV RNA Negative–Status in Patients With Genotype 1b Chronic Hepatitis C

T. Ide, M. Sata, Reiichiro Kuwahara, 2009, The American Journal of Gastroenterology.

The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C.

T. Ide, R. Kumashiro, M. Sata, 2012, The Kurume medical journal.

Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1

T. Ide, M. Sata, T. Torimura, 2012, Journal of Gastroenterology.

A pilot study of eicosapentaenoic acid therapy for ribavirin-related anemia in patients with chronic hepatitis C.

T. Ide, R. Kumashiro, M. Sata, 2003, International journal of molecular medicine.

Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report.

T. Ide, R. Kumashiro, M. Sata, 2006, Hepatology Research.

Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1

T. Ide, H. Kumemura, Y. Eguchi, 2016, PloS one.

Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report.

T. Ide, R. Kumashiro, M. Sata, 2003, Alcoholism, clinical and experimental research.

[A case of drug induced liver injury related pioglitazone].

T. Ide, H. Koga, R. Kumashiro, 2003, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C.

K. Tanikawa, T. Ide, R. Kumashiro, 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C

K. Tanikawa, T. Ide, R. Kumashiro, 2002 .

Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis

T. Ide, R. Kumashiro, M. Sata, 2013, Clinical Journal of Gastroenterology.